Hap Trading, LLC Novavax Inc Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	BUY	$69.73 - $142.9 $2.95 Million - $6.05 Million	42,367 Added 190.23%	64,638 $4.76 Million
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $1.26 Million - $2.04 Million	9,367 Added 72.59%	22,271 $3.19 Million
Q3 2021 Nov 10, 2021	SELL	$177.8 - $270.58 $4.6 Million - $6.99 Million	-25,851 Reduced 66.7%	12,904 $2.68 Million
Q3 2020 Nov 13, 2020	BUY	$79.44 - $178.51 $402,284 - $903,974	5,064 Added 15.03%	38,755 $4.2 Million
Q2 2020 Aug 10, 2020	BUY	$13.86 - $83.61 $466,957 - $2.82 Million	33,691 New	33,691 $2.81 Million

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $666M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.